Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrin treatment for chronic wounds
NL-OMON50490Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Chronic wound, sponsored by Erasmus MC. Primary endpoint: Number of completely healed wounds during 12 weeks. Started Dec 2018; status: recruiting.
02
Conditions
Chronic wound
Beyond the preview
Go deeper on NL-OMON50490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50490.